Mycophenolate mofetil Recruiting Phase 2 Trials for Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome / Refractory Anemia / Leukemia, Prolymphocytic / Myelodysplastic Syndrome / Ann Arbor Stage IV Burkitt Lymphoma / Progressive Disease / Adult Acute Myeloid Leukemia in Remission / Ann Arbor Stage I Burkitt Lymphoma / Lymphoma, Lymphoblastic / Refractory Anemia With Excess Blasts / Recurrent Follicular Lymphoma / Ann Arbor Stage IV Non-Hodgkin Lymphoma / Adult Acute Lymphoblastic Leukemia in Complete Remission / Recurrent Non-Hodgkin Lymphoma / Myelodysplastic Syndrome With Excess Blasts / Acute Lymphoblastic Leukemia in Remission / Burkitt's Lymphoma / Beta-2-Microglobulin Greater Than 3 g/mL / Recurrent Marginal Zone Lymphoma / Chromosome 13 Abnormality / Childhood Acute Lymphoblastic Leukemia in Complete Remission / Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Ann Arbor Stage III Burkitt Lymphoma / Mantle Cell Lymphoma (MCL) / Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive / B Acute Lymphoblastic Leukemia With t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) / Recurrent Small Lymphocytic Lymphoma / Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1 / Aggressive Non-Hodgkin Lymphoma / Ann Arbor Stage I Non-Hodgkin Lymphoma / Plasma Cell Myeloma / chronic, recurrent Lymphocytic Leukemia / Blasts Under 5 Percent of Bone Marrow Nucleated Cells / High Risk Acute Myeloid Leukemia / Acute myeloid leukaemia (in remission) / Pancytopenia / Recurrent Childhood Acute Myeloid Leukemia / Agnogenic Myeloid Metaplasia / Ann Arbor Stage III Non-Hodgkin Lymphoma / Recurrent Lymphoplasmacytic Lymphoma / Ann Arbor Stage II Burkitt Lymphoma / Ann Arbor Stage II Non-Hodgkin Lymphoma / Acute Biphenotypic Leukemia (ABL) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00719888Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease